Aptevo Therapeutics Announces New Solid Tumor Strategy - SEC Filing
APVO•Aptevo files SEC update on new solid tumor strategy
- Aptevo Therapeutics Inc. said it is announcing a new solid tumor strategy in an SEC filing.
- The company also said it has filed a patent application for a nectin-4 x PD-L1 dual-targeting backbone in the same SEC filing.




